School of Medicine
Showing 21-40 of 72 Results
-
Edward Graves
Associate Professor of Radiation Oncology (Radiation Physics) and, by courtesy, of Radiology (Molecular Imaging Program at Stanford)
Current Research and Scholarly InterestsApplications of molecular imaging in radiation therapy, development of hypoxia and radiosensitivity imaging techniques, small animal image-guided conformal radiotherapy, image processing and analysis.
-
Thomas Guenther
Postdoctoral Scholar, Molecular Imaging Program at Stanford
Current Research and Scholarly InterestsCurrent research projects include the development of:
1) Gastrin-releasing peptide receptor (GRPR) targeted radiotheranostics (Cu-64, Ga-68, Tb-161, Lu-177, amongst others)
2) Radiohybrid-based cholecystokinin-2 receptor (CCK-2R) targeted radiotheranostics (F-18, Lu-177)
3) Radiotherapeutics for targeted alpha-particle therapy
4) Radiotheranostics for novel targets
All projects have a strong focus on clinical translation -
Frezghi Habte
Director, Stanford Center for Innovations in In vivo Imaging (SCi3), Stanford Center for Innovation and In Vivo Imaging
Current Role at StanfordDirector, Stanford Center for Innovation, in In vivo Imaging
-
Ka Chun Ho
Lab Assistant I, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordLab Assistant I - Stanford University, Cyclotron & Radiochemistry Facility
-
Michelle L. James
Assistant Professor of Radiology (Molecular Imaging Program at Stanford) and of Neurology (Neurology Research Faculty)
Instructor, Radiology- Molecular Imaging Program at StanfordCurrent Research and Scholarly InterestsThe primary aim of my lab is to improve the diagnosis and treatment of brain diseases by developing translational molecular imaging agents for visualizing neuroimmune interactions underlying conditions such as Alzheimer’s disease, multiple sclerosis, and stroke.
-
Mausam Kalita
Physical Science Research Professional 2, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordSenior Research Scientist: a) cold chemical synthesis— Synthesis of the 12C and 19F- HPLC standards and precursors for 11C- and 18F- labeling
b) Radiosynthesis— Introduction of 11C or 18F radioisotopes into small molecules to develop novel PET tracers, that can track activated myeloid cells in neurodegenerative disease, c) radiometal labeling— 64Cu and 89Zr labeling of monoclonal antibodies that target immune receptors, d) clinical translation— To follow FDA guidelines for translating preclinically validated tracers into humans in the cyclotron and radiochemistry facility (CRF) of the Stanford University -
Jeffrey Howard Kleck
Adjunct Professor, Rad/Molecular Imaging Program at Stanford
BioJeff Kleck, Ph.D.
Adjunct Professor at Stanford University
Facilitates the creation of advanced initiatives for AI in medicine and imaging.
Advises the University on long-term strategies and mentors students and faculty.
Tech Venture Leader & Entrepreneur
General Partner at Eleven of Ten (ELEVENS)
Leverages AI expertise to accelerate breakthrough ventures across health tech, med tech, and other sectors.
Engages with clients like The Bill & Melinda Gates Foundation to drive healthcare innovation.
Chairman of Open Power & Energy Network (OPEN)
Develops sustainable energy solutions using cutting-edge technologies.
Advises the United States Congress on power and energy policy.
Leads initiatives to address global climate challenges through renewable energy.
Government Advisor & National Security Expert
Senior Advisor to the U.S. Department of Defense (DoD)
Advises on strategic initiatives in cybersecurity, communications, and information systems.
Acts as a liaison between Silicon Valley innovation and Pentagon strategies.
Former Director of the Cyber & Telecommunications Portfolio at DoD's Defense Innovation Unit (DIU)
Directed transformative capabilities to shape the future of cybersecurity for national security.
Holds NATO COSMIC TOP SECRET ATOMAL and Top Secret Sensitive Compartmented Information (TS SCI) security clearances.
Academic Leadership
Dean of Academics & Chairman of Entrepreneurship & Technology Commercialization at Catholic Institute of Technology (CIT)
Develops partnerships with Vatican universities and leading institutions.
Oversees programs blending academic excellence with entrepreneurial principles.
Previous Appointments
Adjunct Professor at UCLA, contributing to advancements in radiation therapy and medical imaging.
Visiting Scientist at Lawrence Berkeley National Laboratory and Los Alamos National Laboratory.
Pioneering Technology and Business Ventures
President and Board Member at Rapid AI
Guided the company to become a market leader in AI for brain imaging.
Enhanced stroke diagnosis and treatment, impacting patient outcomes globally.
Founder, CEO, and Chairman of Neoforma and Attainia
Led business-to-business eCommerce in healthcare, taking Neoforma public on NASDAQ.
Launched early ASP/SaaS/Cloud companies, transforming the healthcare supply chain.
Education
Ph.D. in Biomedical Physics, UCLA
MS in Engineering Management, Stanford University
MS in Nuclear Engineering, Texas A&M University
BS in Nuclear Engineering, Texas A&M University
Recognition & Awards
Commander of Ukraine Armed Forces Award — Military Medal, 2023
US DoD CIO Annual Award for Team Cyber & IT Excellence, 2019
Additional Roles & Activities
Friend of Playground Global
Supports the incubation of groundbreaking ventures at a premier deep tech venture capital firm.
California Guard
Serving as Lieutenant Colonel (ARMY), assigned to The Military Department Headquarters.
Actively drives innovation and fosters a holistic approach to technology commercialization. -
Jason Thanh Lee
Deputy Director, Molecular Imaging Program, Rad/Molecular Imaging Program at Stanford
BioBiomedical imaging scientist in preclinical molecular and nuclear imaging, particularly employing PET, CT and optical techniques. Applications include therapeutic development, oncology, immunotherapy, neuroscience, and molecular biology. Active in translational diagnostics research and development. Lead a scientific team and skilled in project management with a portfolio of academic and pharmaceutical/biotechnology partners. Broad foundation in molecular biology assays and in vivo disease models.
-
Craig Levin
Professor of Radiology (Molecular Imaging Program at Stanford/Nuclear Medicine) and, by courtesy, of Physics, of Electrical Engineering and of Bioengineering
On Partial Leave from 09/02/2024 To 10/20/2024Current Research and Scholarly InterestsMolecular Imaging Instrumentation
Laboratory
Our research interests involve the development of novel instrumentation and software algorithms for in vivo imaging of cellular and molecular signatures of disease in humans and small laboratory animal subjects. -
Ning Lu
Postdoctoral Scholar, Molecular Imaging Program at Stanford
BioNing Lu received a joint Ph.D. degree in Biomedical Engineering and Scientific Computing from the University of Michigan, Ann Arbor, USA, in 2023. Previously, she earned a B.S.E. degree (highest honors) in Biomedical Engineering from Southeast University, Nanjing, China, in 2018. From May 2022 to September 2022, she worked at Meta (formerly Facebook) Reality Labs as a research scientist intern on ultrasonic eye tracking for AR/VR wearable devices, in Redmond, Washington, USA. Her research interests include ultrasound instrumentation, ultrasound therapy, ultrasound imaging algorithms, and AI in healthcare.
-
Rim Malek
Postdoctoral Scholar, Molecular Imaging Program at Stanford
Current Research and Scholarly InterestsMy work is focused on the development of small molecules radiotracers for cancer imaging, and small molecules and peptides theranostics for cancer detection, targeted radionuclide therapy, and monitoring of tumor response to therapy.
-
Noeen Malik, PhD
Industry Partnership Lead, Lead Radiochemist, R & D Scientist Engineer, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordIndustry Partnership Lead
CRF, MIPS, Stanford School of Medicine, Stanford | May 2024 — present
Lead Radiochemist (R & D Scientist Engineer 2)
CRF, MIPS, Stanford School of Medicine, Stanford | March 2023 — present
Physical Science Research Scientist
CRF, MIPS, Stanford School of Medicine, Stanford | January 2022 — March 2023
Responsibilities:
• R & D of radiopharmaceuticals for oncology and neuroscience
• Industrial collaborations and partnerships
• Drafting and filing drug applications with regulatory agencies (CMCs, INDs)
• Documentation control for audits and in compliance with FDA, Boards of Pharmacy, USP, NRC, and PET CGMP standards.
• Market strategic report for theragnostic-isotopes for Nextgen Cyclotron project
• CRF website development
https://cyclotron.stanford.edu/
